Glaukos Gets $30M For Glaucoma Treatments

Laguna Hills-based Glaukos, which is developing a medical device for treating glaucoma, said this week that it has raised $30M in a funding round. The Series F funding was led by Meritech Capital Partners, and also included Versant Ventures, Domain Associates, Montreux Equity Partners, InterWest Partners, Frazier Healthcare, OrbiMed Advisors and Gund Investment Corp. Glaukos is developing a stent which relieves eye pressure during cataract surgery. More information »